News
DLBCL: PFS but no OS benefit with polatuzumab-vedotin add-on
Pending additional follow-up for overall survival, is the extra cost worth it?
Pending additional follow-up for overall survival, is the extra cost worth it?
The findings “may be a direct reflection of the challenges women with all types of disabilities face when accessing and receiving care, which is...
One in five U.S. children and adolescents aged 3-17 suffer from a mental, emotional, developmental, or behavioral disorder.
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
The second COVID-19 wave brought zero deaths and fewer complicated hospitalizations at the largest U.S. adult sickle cell disease center, but care...
The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.
Congress should consider the lessons learned over the past 20 months to ensure that health care providers have the flexibility to meet the needs...
“We don’t yet know how many people in Vancouver may have received treatment from the fraudulent nurse.”
Dr. Edwards is a Resident in the Department of Medicine, University of Florida College of Medicine, Gainesville.
Dr. Duff is Professor of...